Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 24, 2026 07:30 ET | Source: Mainz BioMed NV

Mainz Biomed to Present at the Pancreatic Cancer Session at Digestive Disease Week, Demonstrating Effectiveness of mRNA Biomarkers in Blood Samples

Mainz Biomed to Present at the Pancreatic Cancer Session at Digestive Disease Week, Demonstrating Effectiveness of mRNA Biomarkers in Blood Samples
February 17, 2026 07:30 ET | Source: Mainz BioMed NV

Mainz Biomed Announces 6.0 USD Million Private Placement and Strategic Update

Mainz Biomed Announces 6.0 USD Million Private Placement and Strategic Update
January 14, 2026 09:15 ET | Source: Mainz BioMed NV

Mainz Biomed to Present Results of Pancreatic Cancer Verification Study at AACR 2026 Annual Meeting

Mainz Biomed to Present Results of Pancreatic Cancer Verification Study at AACR 2026 Annual Meeting
January 05, 2026 09:15 ET | Source: Mainz BioMed NV

Mainz Biomed Provides Review of 2025 Highlights

Mainz Biomed Provides Review of 2025 Highlights
December 02, 2025 08:01 ET | Source: Mainz BioMed NV

DoctorBox Adds Mainz Biomed’s ColoAlert(R) to Its Portfolio

DoctorBox Adds Mainz Biomed’s ColoAlert® to Its Portfolio
November 18, 2025 08:01 ET | Source: Mainz BioMed NV

Mainz Biomed and OncoVanguard8 Enter into Agreement to bring ColoAlert to South America

Mainz Biomed and OncoVanguard8 Enter into Agreement to bring ColoAlert to South America
November 12, 2025 08:01 ET | Source: Mainz BioMed NV

Mainz Biomed Showcases Innovative Cancer Detection Solutions at MEDICA 2025

Mainz Biomed Showcases Innovative Cancer Detection Solutions at MEDICA 2025
November 10, 2025 08:01 ET | Source: Mainz BioMed NV

Mainz Biomed to Attend the 38th Annual Meeting of the Gastroenterological Working Group of Rhineland-Palatinate (GARPS)

Mainz Biomed to Attend the 38th Annual Meeting of the Gastroenterological Working Group of Rhineland-Palatinate (GARPS)
October 15, 2025 09:01 ET | Source: Mainz BioMed NV

Mainz Biomed to Attend 2025 Maxim Growth Summit

Mainz Biomed N.V. to Attend 2025 Maxim Growth Summit
October 08, 2025 09:00 ET | Source: Mainz BioMed NV

Mainz Biomed Reports Topline Results from Feasibility Study of Biomarker Panel in Pancreatic Cancer Project

Mainz Biomed Reports Topline Results Pancreatic Study - Study Demonstrated a Sensitivity of 100% and Specificity of 95%